StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Mankind Pharma Limited
NSE:MANKIND.NS
Sector
Location
Market Cap
USD 12.41 B
Share Price
USD 30.08
Avg Daily Volume
441,236
Change (1 day)
0.45%
Change (1 year)
17.53%
Change (YTD)
-10.61%
Mankind Pharma Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2025: USD 315.06 M
Mankind Pharma Limited Selling, General, and Administrative Expenses (SG&A) is USD 315.06 M for the year ending March 31, 2025, a -9.44% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
Mankind Pharma Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2024 was USD 347.90 M, a 94.68% change year over year.
-
Mankind Pharma Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2023 was USD 178.70 M, a 106.03% change year over year.
-
Mankind Pharma Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2022 was USD 86.74 M, a 21.59% change year over year.
-
Mankind Pharma Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2021 was USD 71.33 M, a 51.28% change year over year.
Competitors
Zydus Lifesciences Limited
USD 11.28
ZYDUSLIFE.NS
+0.05
0.44%
Ipsen S.A.
USD 131.26
IPN.PA
+0.75
0.57%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
-0.00
-1.65%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.72
600062.SS
-0.01
-0.35%
Eli Lilly and Company
USD 812.69
LLY
+7.26
0.90%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
Zydus Lifesciences Limited
USD 11.28
ZYDUSLIFE.NS
+0.05
0.44%
Ipsen S.A.
USD 131.26
IPN.PA
+0.75
0.57%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
-0.00
-1.65%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.72
600062.SS
-0.01
-0.35%
Eli Lilly and Company
USD 812.69
LLY
+7.26
0.90%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%